boost for global diclofenac gel market, page-3

Oh, if only POH could send out such info on a grander scale- momentum and commitment to the Co would dramatically increase and bolster the lagging S.P.

JF, I am also in no doubt that the company will in some way be able to leverage these findings to their advantage. To date, this obviously would not have been possible, as these study results were only published last Tuesday. POH holds the key (TPM) for the pharma that wishes to establish No. 1 position in a global market that has suddenly got much bigger. For those suffering from knee OA pain, hype counts for little. Other than cost, efficacy is everything. Thus, the most effective topical diclofenac treatment will be the big winner. And that will be the one with TPM!

Sadly, even wider communication of these findings would, imo, do little to change POH's current sp. The market is waiting for solid deal announcements.

Anyway, I hope that these findings inspired you more than Mr. Belfort's stock tips! :)